Reid McCarthy - 20 Nov 2023 Form 4/A - Amendment Insider Report for Annovis Bio, Inc. (ANVS)

Role
Director
Signature
/s/ Henrey Hagopian III, Attorney-in-Fact for Reid McCarthy
Issuer symbol
ANVS
Transactions as of
20 Nov 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
22 Nov 2023, 16:24:29 UTC
Date Of Original Report
21 Nov 2023
Previous filing
03 Jul 2024
Next filing
11 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANVS Common Stock Other $0 0 0% $0.000000* 7,305 20 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed solely to reverse the previously reported purchase on the original form 4 filed on November 21, 2023 (the "Original Form 4"). Such purchase was rescinded by the registrant and the reporting person on November 22, 2023.